Stay updated with breaking news from Cell Based Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, NY / ACCESSWIRE / May 23, 2024 / Logiq, Inc. (OTC Markets:LGIQ) ("Logiq" or "the Company"), a pioneering force in digital consumer acquisition solutions, today revealed the signing of a binding
Why building expertise in multiplex immunofluorescence is critical in a translational clinical research setting
Why building expertise in multiplex immunofluorescence is critical in a translational clinical research setting
Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to...
The microscale device opens up the possibility of cell-based therapy, such as treating Type 1 or Type 2 diabetes utilising the eye as a foundation. | Health